Tourette Disorder
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Emalex BiosciencesEcopipam Hydrochloride
Angeles TherapeuticsD-cycloserine
Clinical Trials (2)
Total enrollment: 236 patients across 2 trials
Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults
Start: Jan 2023Est. completion: Feb 2025216 patients
Phase 3Completed
Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo
Start: Oct 2015Est. completion: Aug 201720 patients
N/ACompleted
Related Jobs
Head of Manufacturing Science & Technology (m/w/d)
Troisdorf, North Rhine-Westphalia, Germany
4w ago
Fachlagerist (m/w/d)
Troisdorf, North Rhine-Westphalia, Germany
1mo ago
Laborleiter – Rohstoffe & Packmittel (m/w/d)
Troisdorf, North Rhine-Westphalia, Germany
1mo ago
Medical Representative
Remote
1mo ago
Accounting Manager (m/w/d)
Bad Homburg, Hesse, Germany
1mo ago
Supply Chain Administrator (m/w/d)
Troisdorf, North Rhine-Westphalia, Germany
1mo ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.